Eureka Therapeutics is a clinical-stage biopharmaceutical company that has the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
The company believes that T-cell therapy represents a revolutionary step towards providing a potential cure for several forms of cancer, including cancers that are poorly addressed by the current approaches. Eureka's mission is to develop safe and effective T-cell therapies that are broadly accessible to the patients as the standard of care for the treatment of several hematologic and solid tumors.
The company’s proprietary ARTEMIS® platform was created to mimic the natural biology of T-cells to fight cancer. Its ARTEMIS® platform is a novel T-cell therapy construct, that is intended to create safer and potentially more effective T-cell therapies than are currently available.
Eureka's proprietary E-ALPHA® antibody discovery platform comprises of a diverse human-derived antibody phage library of over 100 billion clones with unique antibody sequences and a robust workflow that is designed to enable the company to develop specific antibodies against target antigens, including peptide-MHC complexes and cell surface proteins.
Eureka Therapeutics is currently developing a pipeline of novel cancer therapeutics targeting intracellular and cell-surface targets.
Eureka Therapeutics Announces Data Presentations Validating Its Proprietary E-ALPHA Discovery Platform at the 2018 ASH Annual Meeting
Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies
Eureka Therapeutics Inc. and Boehringer Ingelheim Announce a Collaboration to Identify Next Generation Antibodies for Cancer Treatment
Dr Reinhard Malin
Eureka Therapeutics raises $21 million in Series C to expand cancer immunotherapy pipeline
EUREKA THERAPEUTICS, INC.
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- ImmunotherapyImmunotherapy aims to treat disease through activation or suppression of an immune response. For example activating immunotherapies can target cancer and suppressive immunotherapies can target autoimmunity.
- Cancer immunotherapyUse of the immune system to treat cancer